Regina E Groves Atri Cure, Inc. (ATRC) insider trading activity

ATRC Quotes by TradingView

Regina E Groves is Director of AtriCure, Inc.. Currently has a direct ownership of 30,766 shares of ATRC, which is worth approximately $945,131. The most recent transaction as insider was on May 13, 2024, when has been sold 7,788 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
0% 3M change
33.89% 12M change
Total Value Held $945,131

REGINA E GROVES Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
-
7,788 Added 20.2%
30,766 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
3,186 Added 12.18%
22,978 Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
3,564 Added 15.26%
19,792 Common Stock
Sep 15 2021
SELL
Open market or private sale
$235,848 $74.73 p/Share
3,156 Reduced 16.31%
16,194 Common Stock
May 26 2021
SELL
Open market or private sale
$302,766 $71.95 p/Share
4,208 Reduced 17.86%
19,350 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
1,749 Added 6.91%
23,558 Common Stock
Apr 30 2021
BUY
Open market or private purchase
$2,607 $76.68 p/Share
34 Added 0.21%
16,228 Common Stock

Also insider at

FLGT
Fulgent Genetics, Inc. Healthcare
REG

Regina E Groves

Director
Mason, OH

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRC